학술논문
FDA approval: Ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer
Document Type
Review
Author
Amiri-Kordestani, L.; Blumenthal, G.M.; Xu, Q.C.; Zhang, L.; Tang, S.W.; Ha, L.; Weinberg, W.C.; Chi, B.; Candau-Chacon, R.; Hughes, P.; Russell, A.M.; Miksinski, S.P.; Chen, X.H.; McGuinn, W.D.; Palmby, T.; Schrieber, S.J.; Liu, Q.; Wang, J.; Song, P.; Mehrotra, N.; Skarupa, L.; Clouse, K.; Al-Hakim, A.; Sridhara, R.; Ibrahim, A.; Justice, R.; Pazdur, R.; Cortazar, P.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 2014, 20(17):4436-4441)
Subject
Language
English
ISSN
15573265
10780432
10780432